SQUARE PHARMA
===========
FUNDAMENTAL DATA:
================
CATEGORY: DA
FV: 100.00
ML: 1
NAV: 765.68
EPS: 184.56
EPS(2009): 170.51
EPS GROWTH: 8.24
NPAT: 2497.12
NPAT(2009): 2058.38
NPAT GROWTH: 21.31
LAST TRADE PRICE(27-01-2-11): 3497.25
P/E: 18.95
PRICE/NAV: 4.57
ROE: 24.10
AUTHORISED CAPITAL: 5000.00
PAID UP CAPITAL: 1962.00
PUBLIC CAPITAL: 778.61
LDIV:YEND: 35%, 30%B : 0310
RTAG: HY
Comment:
Fundamental Strength:
MEDIUM
TECHNICAL ANALYSIS:
==============
Price and moving averages:
SQURPHARMA has closed above its Short time moving average.
Short time moving average is currently below mid-time, AND below long time moving averages.
The relationship between price and moving averages is:
neutral in short-term, and bearish in mid-long term.
Bollinger Bands:
SQURPHARMA has closed below upper band by 23.1%.
Bollinger Bands are 48.7% narrower than normal.
The narrow width of the bands suggests low volatility as compared to SQURPHARMA()'s normal range. Therefore, the probability of volatility increasing with a sharp price move has increased for the near-term. The bands have been in this narrow range for 21 bars. The probability of a significant price move increases the longer the bands remain in this narrow range.
RSI
Date: 1/30/2011
The RSI is not currently in a topping (above 70) or bottoming (below 30) range.
Failure Swings (also known as support or resistance penetrations or breakouts):The RSI has just reached its highest value in the last 14 period(s). This is bullish.
Divergence:
The RSI has set a new 14-day high while the security price has not. This is a bullish divergence.
MACD
MACD Value: -29.401, Signal Line: -50.951
Crossovers:
Currently the MACD is bullish since it is trading above its signal line.
The MACD crossed above its signal line 2 period(s) ago.
Overbought/Oversold:
The MACD is not in an Overbought/Oversold range.
Divergence:
There have been no divergence signals within the last 5 periods.
CAUTION:This commentary is not a recommendation to buy or sell. Use at your own risk.
DSE SMALL INVESTORS PLATFORM (DSIP)
> INDIVIDUAL STOCK ANALYSIS > PHARMACEUTICALS AND CHEMICALS
SQUARE PHARMA
OFFLINE